GGrantIndex
← Leaderboards

Laurie L Parker

University Of Chicago

$8,784,661
Attributed
$9,585,944
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,585,944 · 13

By mechanism

R33$3,706,346 · 3
R01$3,578,949 · 2
R00$785,414 · 1
R21$730,820 · 2
K99$279,262 · 1
R41$211,754 · 1

Top collaborators

Most similar at University Of Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Phosphotransferases

Research focus

PhosphotransferasesPeptidesCellsMalignant NeoplasmsSignal TransductionTechnologyMonitorDetectionDesignBaseBiologicalBiosensorComplexPhosphorylationValidationIn VitroProtocols DocumentationSamplingDrug DevelopmentResistanceBiologyCell LineDrug DiscoveryPharmaceutical Preparations

Grant awards (46)

Multiplexed proteomics-based kinase assay development$313,840
R01 · FY2025 · GM · contact PI
Tools for measuring post-translational modification enzyme activity in vitro and in cells$188,627
R35 · FY2025 · GM · contact PI
Multiplexed proteomics-based kinase assay development$31,209
R01 · FY2025 · GM · contact PI
Multiplexed proteomics-based kinase assay development$313,840
R01 · FY2024 · GM · contact PI
Multiplexed proteomics-based kinase assay development$85,827
R01 · FY2024 · GM · contact PI
Multiplexed proteomics-based kinase assay development$313,840
R01 · FY2023 · GM · contact PI
Multiplexed proteomics-based kinase assay development$112,963
R01 · FY2023 · GM · contact PI
Multiplexed proteomics-based kinase assay development$10,075
R01 · FY2023 · GM · contact PI
High-Throughput Screening Platform for Cancer Drug Discovery$703,796
R33 · FY2022 · CA
Multiplexed proteomics-based kinase assay development$327,590
R01 · FY2022 · GM · contact PI
High-Throughput Screening Platform for Cancer Drug Discovery$669,017
R33 · FY2021 · CA
Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity$351,213
R33 · FY2019 · CA · contact PI
Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity$99,636
R33 · FY2019 · CA · contact PI
Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity$362,337
R33 · FY2018 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$296,470
R01 · FY2018 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$177,758
R01 · FY2018 · CA · contact PI
Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity$102,718
R33 · FY2018 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$15,958
R01 · FY2018 · CA · contact PI
US HUPO 2018: Technology accelerating discovery$12,000
R13 · FY2018 · CA
Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity$345,244
R33 · FY2017 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$296,470
R01 · FY2017 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$150,049
R01 · FY2017 · CA · contact PI
Expanding multiplexed kinase biosensor analysis to SWATH-MS (1 of 2)$76,541
R33 · FY2017 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$69,920
R01 · FY2017 · CA · contact PI
Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp$331,977
R33 · FY2016 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$301,271
R01 · FY2016 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$69,920
R01 · FY2016 · CA · contact PI
Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp$322,413
R33 · FY2015 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$312,459
R01 · FY2015 · CA · contact PI
A biochemical companion diagnostic platform to measure kinase inhibitor pharmacodynamics in leukemia$211,754
R41 · FY2015 · CA
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$53,962
R01 · FY2015 · CA · contact PI
Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp$341,454
R33 · FY2014 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$173,917
R01 · FY2014 · CA · contact PI
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer$151,611
R01 · FY2014 · CA · contact PI
Biosensor design for detection and analysis of complex signal patterns in cancer$232,965
R00 · FY2012 · CA · contact PI
Biosensor technology to monitor leukemia-related kinase activity in patient cells$190,336
R21 · FY2012 · CA · contact PI
Label-free, real-time detection of kinase activity in vitro and in single cells u$187,043
R21 · FY2012 · CA · contact PI
Biosensor design for detection and analysis of complex signal patterns in cancer$239,546
R00 · FY2011 · CA · contact PI
Label-free, real-time detection of kinase activity in vitro and in single cells u$187,510
R21 · FY2011 · CA · contact PI
Biosensor technology to monitor leukemia-related kinase activity in patient cells$165,931
R21 · FY2011 · CA · contact PI
Biosensor design for detection and analysis of complex signal patterns in cancer$63,904
R00 · FY2011 · CA · contact PI
Biosensor design for detection and analysis of complex signal patterns in cancer$248,999
R00 · FY2010 · CA · contact PI
Biosensor design for detection and analysis of complex signal patterns in cancer$139,631
K99 · FY2009 · CA · contact PI
Biosensor design for detection and analysis of complex signal patterns in cancer$139,631
K99 · FY2008 · CA · contact PI
Bcr-Abl thiophosphorylation profiling in CML using MALDI$48,796
F32 · FY2006 · CA · contact PI
Bcr-Abl thiophosphorylation profiling in CML using MALDI$43,976
F32 · FY2005 · CA